Toxicological and pathological findings in a series of buprenorphine related deaths. Possible risk factors for fatal outcome

Forensic Science International

Volumn 220, Issue 1-3, 2012, Pages 284-290

  Seldén, Tor ^a,b   Ahlner, Johan ^a,b   Druid, Henrik ^a,c   Kronstrand, Robert ^a,b  

^a DEPARTMENT OF FORENSIC GENETICS AND FORENSIC TOXICOLOGY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Buprenorphine; Death; Poly drug use; Postmortem toxicology; Respiratory depression

Indexed keywords

ALPRAZOLAM; BUPRENORPHINE; HYPNOTIC AGENT; ILLICIT DRUG; NORBUPRENORPHINE; PSYCHOTROPIC AGENT; SEDATIVE AGENT; TETRAHYDROCANNABINOL;

ADULT; ARTICLE; AUTOPSY; BLOOD ANALYSIS; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG FATALITY; DRUG OVERDOSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FORENSIC PATHOLOGY; FORENSIC TOXICOLOGY; HUMAN; LUNG CONGESTION; LUNG EDEMA; MALE; METABOLITE; MULTIPLE DRUG ABUSE; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RISK ASSESSMENT; RISK FACTOR; TOXICITY TESTING; URINALYSIS;

EID: 84862683744     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2012.03.016     Document Type: Article

References (48)

1. Megarbane B., Hreiche R., Pirnay S., Marie N., Baud F.J. Does high-dose buprenorphine cause respiratory depression? Possible mechanisms and therapeutic consequences. Toxicol. Rev. 2006, 25:79-85.
2. Gueye P.N., Borron S.W., Risede P., Monier C., Buneaux F., Debray M., Baud F.J. Lack of effect of single high doses of buprenorphine on arterial blood gases in the rat. Toxicol. Sci. 2001, 62:148-154.
3. Auriacombe M., Franques P., Tignol J. Deaths attributable to methadone vs buprenorphine in France. JAMA 2001, 285:45.
4. Hakkinen M., Launiainen T., Vuori E., Ojanpera I. Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning. Eur. J. Clin. Pharmacol. 2012, 68:301-309.
5. Kintz P. Deaths involving buprenorphine: a compendium of French cases. Forensic Sci. Int. 2001, 121:65-69.
6. Kintz P. A new series of 13 buprenorphine-related deaths. Clin. Biochem. 2002, 35:513-516.
7. Lai S.H., Yao Y.J., Lo D.S. A survey of buprenorphine related deaths in Singapore. Forensic Sci. Int. 2006, 162:80-86.
8. Pirnay S., Borron S.W., Giudicelli C.P., Tourneau J., Baud F.J., Ricordel I. A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction 2004, 99:978-988.
9. Reynaud M., Petit G., Potard D., Courty P. Six deaths linked to concomitant use of buprenorphine and benzodiazepines. Addiction 1998, 93:1385-1392.
10. Soyka M., Penning R., Wittchen U. Fatal poisoning in methadone and buprenorphine treated patients - are there differences?. Pharmacopsychiatry 2006, 39:85-87.
11. Tracqui A., Kintz P., Ludes B. Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities. J. Anal. Toxicol. 1998, 22:430-434.
12. Megarbane B., Buisine A., Jacobs F., Resiere D., Chevillard L., Vicaut E., Baud F.J. Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment. J. Subst. Abuse Treat. 2010, 38:403-407.
13. Gueye P.N., Borron S.W., Risede P., Monier C., Buneaux F., Debray M., Baud F.J. Buprenorphine and midazolam act in combination to depress respiration in rats. Toxicol. Sci. 2002, 65:107-114.
14. Pirnay S., Megarbane B., Decleves X., Risede P., Borron S.W., Bouchonnet S., Perrin B., Debray M., Milan N., Duarte T., Ricordel I., Baud F.J. Buprenorphine alters desmethylflunitrazepam disposition and flunitrazepam toxicity in rats. Toxicol. Sci. 2008, 106:64-73.
15. Pirnay S.O., Megarbane B., Borron S.W., Risede P., Monier C., Ricordel I., Baud F.J. Effects of various combinations of benzodiazepines with buprenorphine on arterial blood gases in rats. Basic Clin. Pharmacol. Toxicol. 2008, 103:228-239.
16. Darke S., Hall W., Kaye S., Ross J., Duflou J. Hair morphine concentrations of fatal heroin overdose cases and living heroin users. Addiction 2002, 97:977-984.
17. Druid H., Strandberg J.J., Alkass K., Nystrom I., Kugelberg F.C., Kronstrand R. Evaluation of the role of abstinence in heroin overdose deaths using segmental hair analysis. Forensic Sci. Int. 2007, 168:223-226.
18. Fugelstad A., Ahlner J., Brandt L., Ceder G., Eksborg S., Rajs J., Beck O. Use of morphine and 6-monoacetylmorphine in blood for the evaluation of possible risk factors for sudden death in 192 heroin users. Addiction 2003, 98:463-470.
19. Kronstrand R., Grundin R., Jonsson J. Incidence of opiates, amphetamines, and cocaine in hair and blood in fatal cases of heroin overdose. Forensic Sci. Int. 1998, 92:29-38.
20. Kronstrand R., Nystrom I., Strandberg J., Druid H. Screening for drugs of abuse in hair with ion spray LC-MS-MS. Forensic Sci. Int. 2004, 145:183-190.
21. Tagliaro F., De Battisti Z., Smith F.P., Marigo M. Death from heroin overdose: findings from hair analysis. Lancet 1998, 351:1923-1925.
22. Aderjan R., Hofmann S., Schmitt G., Skopp G. Morphine and morphine glucuronides in serum of heroin consumers and in heroin-related deaths determined by HPLC with native fluorescence detection. J. Anal. Toxicol. 1995, 19:163-168.
23. Kronstrand R., Nystrom I., Andersson M., Gunnarsson L., Hagg S., Josefsson M., Ahlner J. Urinary detection times and metabolite/parent compound ratios after a single dose of buprenorphine. J. Anal. Toxicol. 2008, 32:586-593.
24. Skopp G., Lutz R., Ganssmann B., Mattern R., Aderjan R. Postmortem distribution pattern of morphine and morphine glucuronides in heroin overdose. Int. J. Legal Med. 1996, 109:118-124.
25. Elkader A., Sproule B. Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. Clin. Pharmacokinet. 2005, 44:661-680.
26. Kuhlman J.J., Lalani S., Magluilo J., Levine B., Darwin W.D. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. J. Anal. Toxicol. 1996, 20:369-378.
27. Harris D.S., Mendelson J.E., Lin E.T., Upton R.A., Jones R.T. Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality. Clin. Pharmacokinet. 2004, 43:329-340.
28. Greenwald M.K., Johanson C.E., Moody D.E., Woods J.H., Kilbourn M.R., Koeppe R.A., Schuster C.R., Zubieta J.K. Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. Neuropsychopharmacology 2003, 28:2000-2009.
29. George S., George C., Chauhan M. The development and application of a rapid gas chromatography-mass spectrometry method to monitor buprenorphine withdrawal protocols. Forensic Sci. Int. 2004, 143:121-125.
30. Kronstrand R., Selden T.G., Josefsson M. Analysis of buprenorphine, norbuprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry. J. Anal. Toxicol. 2003, 27:464-470.
31. Druid H., Holmgren P. A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J. Forensic Sci. 1997, 42:79-87.
32. Jones A.W., Schuberth J. Computer-aided headspace gas chromatography applied to blood-alcohol analysis: importance of online process control. J. Forensic Sci. 1989, 34:1116-1127.
33. Selden T., Roman M., Druid H., Kronstrand R. LC-MS-MS analysis of buprenorphine and norbuprenorphine in whole blood from suspected drug users. Forensic Sci. Int. 2011, 209:113-119.
34. Ferrant O., Papin F., Clin B., Lacroix C., Saussereau E., Remoue J.E., Goulle J.P. Fatal poisoning due to snorting buprenorphine and alcohol consumption. Forensic Sci. Int. 2011, 204:e8-e11.
35. Megarbane B., Vodovar D., Baud F.J. Fatalities in relation to buprenorphine snorting and ethanol co-ingestion: mechanisms of toxicity. Forensic Sci. Int. 2011, 207:e59-e60.
36. Dahan A. Opioid-induced respiratory effects: new data on buprenorphine. Palliat. Med. 2006, 20(Suppl. 1):s3-s8.
37. Dahan A., Yassen A., Bijl H., Romberg R., Sarton E., Teppema L., Olofsen E., Danhof M. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. Br. J. Anaesth. 2005, 94:825-834.
38. Dahan A., Yassen A., Romberg R., Sarton E., Teppema L., Olofsen E., Danhof M. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br. J. Anaesth. 2006, 96:627-632.
39. Walsh S.L., Preston K.L., Stitzer M.L., Cone E.J., Bigelow G.E. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin. Pharmacol. Ther. 1994, 55:569-580.
40. Megarbane B., Marie N., Pirnay S., Borron S.W., Gueye P.N., Risede P., Monier C., Noble F., Baud F.J. Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation. Toxicol. Appl. Pharmacol. 2006, 212:256-267.
41. Kobayashi K., Yamamoto T., Chiba K., Tani M., Shimada N., Ishizaki T., Kuroiwa Y. Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4. Drug Metab. Dispos. 1998, 26:818-821.
42. Picard N., Cresteil T., Djebli N., Marquet P. In vitro metabolism study of buprenorphine: evidence for new metabolic pathways. Drug Metab. Dispos. 2005, 33:689-695.
43. Rouguieg K., Picard N., Sauvage F.L., Gaulier J.M., Marquet P. Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes. Drug Metab. Dispos. 2010, 38:40-45.
44. Brown S.M., Holtzman M., Kim T., Kharasch E.D. Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically active. Anesthesiology 2011, 115:1251-1260.
45. Pelissier-Alicot A.L., Sastre C., Baillif-Couniou V., Gaulier J.M., Kintz P., Kuhlmann E., Perich P., Bartoli C., Piercecchi-Marti M.D., Leonetti G. Buprenorphine-related deaths: unusual forensic situations. Int. J. Legal Med. 2010, 124:647-651.
46. Krol R.C., Knuth S.L., Bartlett D. Selective reduction of genioglossal muscle activity by alcohol in normal human subjects. Am. Rev. Respir. Dis. 1984, 129:247-250.
47. Robinson R.W., White D.P., Zwillich C.W. Moderate alcohol ingestion increases upper airway resistance in normal subjects. Am. Rev. Respir. Dis. 1985, 132:1238-1241.
48. Druid H., Holmgren P. Fatal injections of heroin. Interpretation of toxicological findings in multiple specimens. Int. J. Legal Med. 1999, 112:62-66.